HKG:3737 Revenue

In the year 2024, Zhongzhi Pharmaceutical Holdings had annual revenue of 2.21B CNY with 8.05% growth. Zhongzhi Pharmaceutical Holdings had revenue of 1.13B in the half year ending December 31, 2024, with 14.99% growth.

Revenue

2.21B CNY

Revenue Growth

+8.05%

P/S Ratio

0.32

Revenue / Employee

859.44K CNY

Employees

2,577

Market Cap

742.70M HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.21B	164.97M	8.05%
Dec 31, 2023	2.05B	223.88M	12.26%
Dec 31, 2022	1.83B	79.44M	4.55%
Dec 31, 2021	1.75B	142.62M	8.89%
Dec 31, 2020	1.60B	261.69M	19.50%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
BeOne Medicines	32.49B
Hansoh Pharmaceutical Group Company	13.05B
Innovent Biologics	10.03B
JD Health International	61.89B
Sino Biopharmaceutical	30.72B
WuXi Biologics	19.87B
Akeso	2.26B
CSPC Pharmaceutical Group	28.99B

Revenue Rankings